v3.25.4
Consolidated Statements of Cash Flows - Manufacturing Group and Finance Group - USD ($)
$ in Millions
 12 Months Ended
Jan. 03, 2026
Dec. 28, 2024
Dec. 30, 2023
Cash flows from operating activities      
Income from continuing operations $ 923 $ 825 $ 922
Non-cash items:      
Depreciation and amortization 401 382 395
Deferred income taxes 155 (48) (192)
Asset impairments and powersports inventory charge 1 41 88
Gain on business disposition (4) 0 0
Other, net 134 102 90
Changes in assets and liabilities:      
Accounts receivable, net 107 (96) (9)
Inventories (264) (194) (359)
Other assets (76) 205 267
Accounts payable 197 (69) 2
Other liabilities 32 95 276
Income taxes, net (45) (26) 4
Pension, net (232) (225) (202)
Other operating activities, net 1 24 2
Net cash provided by operating activities of continuing operations 1,313 1,015 1,267
Net cash used in operating activities of discontinued operations (1) (1) (1)
Net cash provided by operating activities 1,312 1,014 1,266
Cash flows from investing activities      
Capital expenditures (383) (364) (402)
Net proceeds from corporate-owned life insurance policies 80 85 40
Net proceeds from business disposition 16 0 0
Proceeds from sale of property, plant and equipment 9 4 18
Net cash used in business acquisitions (1) (13) (1)
Finance receivables repaid 42 25 26
Finance receivables originated (58) (21) 0
Proceeds from the disposition of non-captive assets 72 0 0
Other investing activities, net 16 0 2
Net cash provided by (used in) investing activities (207) (284) (317)
Cash flows from financing activities      
Net proceeds from long-term debt 991 0 348
Principal payments on long-term debt and nonrecourse debt (720) (377) (44)
Purchases of Textron common stock (822) (1,122) (1,168)
Proceeds from exercise of stock options 40 88 73
Dividends paid (18) (12) (16)
Other financing activities, net (14) (31) (6)
Net cash used in financing activities (543) (1,454) (813)
Effect of exchange rate changes on cash and equivalents 22 (16) 10
Net increase (decrease) in cash and equivalents 584 (740) 146
Cash and equivalents at beginning of year 1,441 2,181 2,035
Cash and equivalents at end of year 2,025 1,441 2,181
Manufacturing group      
Cash flows from operating activities      
Income from continuing operations 878 796 884
Non-cash items:      
Depreciation and amortization 401 382 395
Deferred income taxes 180 (46) (188)
Asset impairments and powersports inventory charge 1 41 88
Gain on business disposition (4) 0 0
Other, net 136 115 110
Changes in assets and liabilities:      
Accounts receivable, net 107 (96) (9)
Inventories (264) (194) (359)
Other assets (74) 205 261
Accounts payable 197 (69) 2
Other liabilities 38 100 281
Income taxes, net (63) (25) 5
Pension, net (232) (225) (202)
Dividends received from Finance group 25 0 0
Other operating activities, net 1 24 2
Net cash provided by operating activities of continuing operations 1,327 1,008 1,270
Net cash used in operating activities of discontinued operations (1) (1) (1)
Net cash provided by operating activities 1,326 1,007 1,269
Cash flows from investing activities      
Capital expenditures (383) (364) (402)
Net proceeds from corporate-owned life insurance policies 80 85 40
Net proceeds from business disposition 16 0 0
Proceeds from sale of property, plant and equipment 9 4 18
Net cash used in business acquisitions (1) (13) (1)
Finance receivables repaid 0 0 0
Finance receivables originated 0 0 0
Proceeds from the disposition of non-captive assets 0 0 0
Other investing activities, net 15 0 0
Net cash provided by (used in) investing activities (264) (288) (345)
Cash flows from financing activities      
Net proceeds from long-term debt 991 0 348
Principal payments on long-term debt and nonrecourse debt (707) (361) (7)
Purchases of Textron common stock (822) (1,122) (1,168)
Proceeds from exercise of stock options 40 88 73
Dividends paid (18) (12) (16)
Other financing activities, net (14) (31) (6)
Net cash used in financing activities (530) (1,438) (776)
Effect of exchange rate changes on cash and equivalents 22 (16) 10
Net increase (decrease) in cash and equivalents 554 (735) 158
Cash and equivalents at beginning of year 1,386 2,121 1,963
Cash and equivalents at end of year 1,940 1,386 2,121
Finance group      
Cash flows from operating activities      
Income from continuing operations 45 29 38
Non-cash items:      
Depreciation and amortization 0 0 0
Deferred income taxes (25) (2) (4)
Asset impairments and powersports inventory charge 0 0 0
Gain on business disposition 0 0 0
Other, net (2) (13) (20)
Changes in assets and liabilities:      
Accounts receivable, net 0 0 0
Inventories 0 0 0
Other assets (2) 0 6
Accounts payable 0 0 0
Other liabilities (6) (5) (5)
Income taxes, net 18 (1) (1)
Pension, net 0 0 0
Dividends received from Finance group 0 0 0
Other operating activities, net 0 0 0
Net cash provided by operating activities of continuing operations 28 8 14
Net cash used in operating activities of discontinued operations 0 0 0
Net cash provided by operating activities 28 8 14
Cash flows from investing activities      
Capital expenditures 0 0 0
Net proceeds from corporate-owned life insurance policies 0 0 0
Net proceeds from business disposition 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Net cash used in business acquisitions 0 0 0
Finance receivables repaid 208 133 169
Finance receivables originated (241) (130) (160)
Proceeds from the disposition of non-captive assets 72 0 0
Other investing activities, net 1 0 2
Net cash provided by (used in) investing activities 40 3 11
Cash flows from financing activities      
Net proceeds from long-term debt 0 0 0
Principal payments on long-term debt and nonrecourse debt (13) (16) (37)
Purchases of Textron common stock 0 0 0
Proceeds from exercise of stock options 0 0 0
Dividends paid (25) 0 0
Other financing activities, net 0 0 0
Net cash used in financing activities (38) (16) (37)
Effect of exchange rate changes on cash and equivalents 0 0 0
Net increase (decrease) in cash and equivalents 30 (5) (12)
Cash and equivalents at beginning of year 55 60 72
Cash and equivalents at end of year $ 85 $ 55 $ 60